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 The importance of systemic hypertension and endo-thelial dysfunction in causing left ventricular 
(LV) hypertrophy is well defi ned. 1,2 In contrast, data 
regarding the association between peripheral endo-
thelial dysfunction and right ventricular (RV) structure 
and function are scarce. Patients with idiopathic pul-
monary arterial hypertension demonstrate peripheral 
vascular endothelial dysfunction and commonly have 
RV hypertrophy, dilation, and systolic dysfunction. 3-5 
Furthermore, peripheral endothelial function is linked 
to the pulmonary vascular response to vasodilators. 6 
Despite these associations, there has been little inves-
tigation of the relationship between peripheral vascu-
lar endothelial dysfunction and RV morphology, even 
though endothelial dysfunction may precede clinical 
cardiovascular disease and is potentially modifi able. 7-9 
 Brachial artery ultrasonography can assess periph-
eral vascular structure and function. Larger base-
line brachial artery diameter (BD) is independently 
associated with cardiovascular risk factors and an 
increased risk of cardiovascular events. 10,11 The change 
in brachial arterial diameter following occlusion 
of blood fl ow divided by the BD (known as fl ow-
mediated dilation [FMD]) refl ects the capacity for 
endothelial nitric oxide production and is a signifi -
cant predictor of cardiovascular events in population-
based cohort studies, heart failure, and coronary 
disease, and after elective vascular surgery. 11-16 Systemic 
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5,004 participants (98%). Of these, the MESA-Right Ventricle 
ancillary study targeted the interpretation of 4,484 scans and 
successfully read 4,204 scans for RV morphology. 20-25 Brachial artery 
ultrasonography was measured in 6,489 participants. A randomly 
selected sample of 2,844 participants plus 182 participants who 
had a cardiovascular event within 5 years of follow-up had ultra-
sound measurements interpreted (n  5 3,026). Therefore, our study 
sample (n  5 2,425) was composed of the participants with com-
plete covariate data from the intersection of the 3,026 with 
brachial artery ultrasound measurements and the 4,204 with 
interpretable RV function  (Fig 1 ). 
 MRI Protocol and Brachial Artery Ultrasonography 
 The cardiac MRI protocol and methods for interpretation 
of LV and RV parameters in MESA have been reported 
(e-Appendix 1). 23,25,26  BD and FMD were determined using high-
resolution ultrasonography of the brachial artery. 11,16,27 In brief, 
participants were asked to abstain from food, consumption of 
vitamin E or C, and smoking for   6 h before the scan. A standard 
BP cuff was positioned around the right arm, 2 in below the ante-
cubital fossa, and the brachial artery of the right arm was imaged 
5 to 9 cm above the antecubital fossa using a 9-MHz linear array 
transducer (M12L transducer; GE Healthcare). Digitized images 
of the right brachial artery were captured continuously for 30 s 
before cuff infl ation (BD). To induce reactive hyperemia, the 
brachial artery was occluded for 5 min at an occlusion cuff pres-
sure of   50 mm Hg above the participant’s systolic BP. Digi-
tized images were recorded for 2 min beginning immediately 
before cuff defl ation to document the vasodilator response. Data 
were analyzed using a validated semiautomated system. 16,28 FMD 
was expressed as the percentage of increase in the brachial artery 
diameter (media-adventitial interface to the media-adventitial 
interface) with reactive hyperemia: FMD  5 ([peak brachial artery 
diameter after cuff defl ation  2 BD]/BD)  3 100. 
 Intrasubject variability was evaluated by comparing results from 
repeated examinations of 19 subjects on 2 days, 1 week apart. 
The intraclass correlation coeffi cients for BD, peak diameter, and 
FMD were 0.90, 0.90, and 0.54, respectively. The intrareader 
intraclass correlation coeffi cients for BD, peak diameter, and 
FMD were 0.99, 0.99, and 0.93, respectively, from 40 scans. Per-
centage technical errors of measurement for BD, peak diameter, 
and FMD were 1.39%, 1.47%, and 28.4%, respectively. 16 
 Covariates and Statistical Analysis 
 See e-Appendix 1 for information on the covariates . Multi-
variable linear regression was used to assess the relationship of 
BD and FMD (independent variables) with RV mass, RVEDV, 
and RVEF (dependent variables) (e-Appendix 1). All analyses 
were adjusted for height, weight, and waist circumference, 
so it was not necessary to index the RV parameters to account 
for differences in body size. Analyses were performed using 
STATA 11.0 (StataCorp LP).  P values  , .05 were considered 
statistically signifi cant. 
 Results 
 There were 2,455 participants with measurement 
of RV morphology and brachial artery ultrasonog-
raphy. We excluded 30 participants with missing 
covariate data, leaving 2,425 in the fi nal study sample 
( Fig 1 ). The mean age was 60.9 years, and 49.4% 
were men ( Table 1 ). Approximately one-third were 
white, 21.0% were black, 25.1% were Hispanic, and 
vascular structure and function may be linked to 
RV morphology by refl ecting right coronary perfu-
sion, the neurohormonal milieu, and/or pulmonary 
vascular dysfunction and increased RV afterload. 17,18 
The purpose of this study was to evaluate the rela-
tionship between BD and FMD and RV mass, RV end-
diastolic volume (RVEDV), and RV ejection fraction 
(RVEF) in a population free of clinical cardiovascu-
lar disease. 
 Materials and Methods 
 The Multi-Ethnic Study of Atherosclerosis (MESA) is a 
multicenter prospective cohort study to investigate the preva-
lence, correlates, and progression of subclinical cardiovascular 
disease in whites , blacks , Hispanics, and Chinese. 19 In 2000-2002, 
MESA recruited 6,814 men and women aged 45 to 84 years old 
from six US communities: Forsyth County, North Carolina; 
Northern Manhattan and the Bronx, New York; Baltimore 
City and Baltimore County, Maryland; St. Paul, Minnesota; 
Chicago, Illinois; and Los Angeles, California. Exclusion crite-
ria included clinical cardiovascular disease (physician diagnosis 
of heart attack, stroke, transient ischemic attack, heart failure, 
angina, current atrial fi bril lation, any cardiovascular procedure), 
weight  . 136 kg (300 lbs), pregnancy, or impediment to long-
term participation. Hypertension, diabetes mellitus, and hyper-
lipidemia were not considered as clinical cardiovascular disease 
by the design of the parent study, and subjects with these condi-
tions were therefore eligible for inclusion. Informed consent 
was obtained from all participants. The studies described herein 
were approved by the institutional review board of the University 
of Pennsylvania (No. 808374). 
 Of the 6,814 participants, 5,098 agreed to undergo MRI and 
had no contraindications. LV morphology was interpretable in 
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 FMD was not signifi cantly associated with RV mass 
and RVEF. Higher FMD was associated with statisti-
cally signifi cantly lower RVEDV in the limited and 
adjusted models. However, the effect estimates were 
small ( Table 3 , e-Fig 1). 
 We repeated these analyses after adjusting for spi-
rometry, urine cotinine, and extent of emphysema 
by CT scan in those with available data (n  5 2,300), 
with fi ndings nearly identical to those from the full 
cohort (e-Table 1). Larger BD was signifi cantly asso-
ciated with greater RV mass and larger RVEDV 
in the limited and adjusted models (both  P  , .001). 
This relationship was attenuated but persisted after 
adjustment for the corresponding LV parameter. BD 
appeared to be associated with RVEF in this subset 
but did not reach statistical signifi cance. 
 In those unlikely to have sleep-disordered breath-
ing (SDB) (n  5 743), the effect estimates were sim-
ilar (or larger) compared with those from the main 
analysis (e-Table 2). Larger BD was signifi cantly asso-
ciated with greater RV mass and larger RVEDV in 
the limited and adjusted models (e-Table 2). Finally, 
approximately one-third of our cohort (n  5 839) were 
not obese, were nonsmokers, and did not have hyper-
tension, diabetes mellitus, or impaired fasting glu-
cose. Again, the relationships seen between BD and 
RV parameters in this healthy subset were similar to 
 Figure 1. Study sample. FMD  5 fl ow-mediated dilation; LV  5 left 
ventricular; MESA  5 Multi-Ethnic Study of Atherosclerosis; 
RV  5 right ventricular. 
 Table 1— Characteristics of the Study Sample 
Compared With Those Excluded 
Characteristic 
Study Sample 
(n  5 2,425)
Excluded 
(n  5 4,389)
Age , y 60.9   9.9 62.8   10.4
Male 49.4 45.9
Race/ethnicity
 White 34.2 40.9
 Black 21.0 31.6
 Hispanic 25.1 20.2
 Chinese 19.9 7.3
Height, cm 166.2   9.9 166.5   10.1
Weight, kg 75.8   16.0 80.2   17.8
BMI, kg/m 2 27.3   4.8 28.9   5.8
Educational attainment
 No high school degree 17.4 18.4
 High school degree 24.6 25.8
 Some college 20.2 22.0
 College degree 18.5 16.6
 More than bachelor’s degree 19.3 17.3
Cigarette smoking status
 Never 55.5 47.5
 Former 33.4 38.4
 Current 11.1 14.1
Hypertension medication use 30.5 34.8
Statin use 13.9 15.3
Systolic BP, mm Hg 124.2   19.9 127.9   22.1
Diastolic BP, mm Hg 71.9   10.0 71.9   10.4
Diabetes mellitus (treated 
 or untreated) 
10.5 13.9
Data are presented as mean   SD or %.
19.9% were Chinese. The mean BMI was 27.3 kg/m 2 . 
Those included were somewhat more likely to be 
male, Chinese, and nonsmokers, and less likely to 
be black than were those excluded, but were gener-
ally similar ( Table 1 ). Formal hypothesis testing for 
these comparisons ( P values) is not appropriate and 
was not performed.  Table 2 shows the results of the 
cardiac MRI and brachial artery ultrasonography. 
The mean RVEF was 70.2%   6.5%. The mean BD 
and FMD were 4.30 mm and 4.41%, respectively. 
 Larger BD was signifi cantly associated with greater 
RV mass in the limited and adjusted models (both 
 P  , .001) ( Fig 2A ,  Table 3 ). A 1-mm increase in BD 
corresponded to a 0.55-g higher RV mass in the 
adjusted model. This relationship was attenuated 
but persisted after adjusting for LV mass ( P  5 .001), 
suggesting a relationship between BD and RV mass 
independent of LV mass. Similarly, larger BD was 
signifi cantly associated with greater RVEDV in lim-
ited and adjusted models (both  P  , .001) ( Fig 2B , 
 Table 3 ). A 1-mm increase in BD corresponded to 
a 3.99-mL-larger RVEDV in the adjusted model. 
This relationship was attenuated but persisted after 
adjusting for LV end-diastolic volume ( P  5 .001). 
Larger BD was associated with lower RVEF after 
adjustment for covariates ( P  5 .03) ( Fig 2C ,  Table 3 ). 
Adjustment for LV ejection fraction attenuated this 
association, which still appeared to be present ( P  5 .07). 
There were no differences in these associations by 
sex or race/ethnicity. The relationships between BD 
and RV parameters were present in models without 
adjustment for height, weight, and waist circumfer-
ence and with adjustment for only the corresponding 
LV parameter (eg, RVEF adjusted for LV ejection 
fraction) (data not shown). 
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those from the full study sample (e-Table 3). Power 
to detect signifi cant differences in these smaller sub-
sets was more limited than in our main study sample. 
 Discussion 
 We have shown that larger BD is associated with 
greater RV mass, larger RVEDV, and lower RVEF 
in individuals free of clinical cardiovascular disease. 
These fi ndings were present both before and after 
adjustment for height, weight, and LV mass and vol-
ume, indicating that the relationship was not attrib-
utable to differences in body size or changes in the 
LV. Our fi ndings were not affected by adjustment 
for spirometry, cotinine levels, and extent of emphy-
sema, indicating that the relationship is not due to 
confounding by tobacco use or parenchymal lung 
structure or function. Finally, the results were sim-
ilar in those individuals at low risk of SDB and with-
out other common medical conditions. These data 
suggest that systemic vascular structure may be asso-
ciated with RV morphology independent of any 
concomitant lung, sleep, medical, or LV disorders, 
implying that the peripheral vasculature could be 
an indicator of pulmonary vascular remodeling. The 
relative changes in RV mass with a 1- to 2-mm differ-
ence in BD are similar to those seen for LV mass in 
relation to active smoking or diabetes mellitus in 
MESA. 25 RV hypertrophy and enlargement may be 
associated with increased risks of heart failure and 
cardiovascular death, suggesting clinical relevance. 29 
However, just as with the LV, it is likely overly sim-
plistic to designate increased RV mass as “good” or 
“bad.” There are likely adaptive and maladaptive 
forms of ventricular hypertrophy, which are not nec-
essarily easy to discriminate morphologically. 
 The association of larger BD with greater RV mass 
and volumes seemingly runs counter to the notion 
that diseased arteries become narrowed. However, a 
large body of human and nonhuman primate research 
suggests that systemic arteries remodel and dilate in 
response to cardiovascular risk factors. 30 In an autopsy 
 Table 2— MRI and Brachial Artery Ultrasonography 
Results 
Parameter Study Sample (n  5 2,425 )
RVEDV, mL 125.4   31.4
RV mass, g 21.1   4.3
RVEF, % 70.2   6.5
LVEF, % 69.3   7.2
Baseline brachial artery diameter, mm 4.30   0.82
FMD, % 4.41   2.80
Data are presented as mean   SD. FMD  5 fl ow-mediated dilation; 
LVEF  5 left ventricular ejection fraction; RV  5 right ventricular; 
RVEDV  5 right ventricular end-diastolic volume; RVEF  5 right 
ventricular ejection fraction.
 Figure 2. Fully adjusted linear relationship between base-
line diameter and RV mass, RVEDV, and RVEF. A, RV mass. 
B, RVEDV. C, RVEF. RVEDV  5 right ventricular end-diastolic 
volume; RVEF  5 right ventricular ejection fraction. See Figure 1 
legend for expansion of other abbreviations. 
study, early atherosclerosis was characterized by 
enlargement of coronary vessel and luminal diameter. 31 
Several studies have linked cardiovascular risk factors 
and atherosclerosis with larger luminal diameters of 
the brachial artery and other vascular structures. 10,32-34 
In MESA, larger BD was strongly associated with 
wider retinal venular caliber and smaller retinal arte-
riolar caliber, both validated markers of systemic 
vascular disease. 35 Chung et al 33 found that larger 
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shared milieu of circulating mediators), it is possible 
that remodeling in the systemic and pulmonary ves-
sels may also occur in concert. 
 Finally, BD is associated with coronary artery cal-
cifi cation, which suggests that altered right coro-
nary perfusion could explain the RV morphologic 
changes. 43 Abnormal RV perfusion and ischemia 
adversely affect the ventricle in pulmonary vascular 
disease, even in the absence of epicardial coronary 
artery disease. 44 Subclinical RV perfusion variability 
has not been well studied in participants without 
clinical cardiovascular disease. 
 We did not fi nd a consistent relationship between 
FMD and RV parameters. The variability of FMD 
was much greater than of BD, likely because of 
compounding of the errors from the two measure-
ments necessary to compute this variable. There-
fore, it is possible that measurement error in FMD 
accounts for the discordant results between FMD 
and BD. 
 There were some limitations in our study. As with 
all measures, error in the assessment of brachial 
artery diameters and RV morphology is possible. 
However, potential error in either measurement (as 
long as nondifferential) should bias our results toward 
the null hypothesis, so that the associations may be 
even stronger than we have shown. We attempted 
to account for multiple covariates and perform addi-
tional analyses of healthy subsets; however, residual 
or unmeasured confounding is possible. FMD has 
been linked to the presence of obstructive lung 
disease 45 ; however, our fi ndings were similar after 
adjustment for lung function, suggesting that lung 
disease did not account for the associations. Two 
studies have shown a link between BD and SDB; 
however, the effect estimates were unchanged after 
postsublingual nitroglycerin brachial artery diam-
eter (refl ecting maximal vasodilation) was associ-
ated with cardiovascular risk factors, suggesting the 
importance of arterial remodeling (rather than vas-
cular tone). Larger vessels had proportional increases 
in blood fl ow, consistent with fl ow-induced adap-
tive remodeling. 
 Larger BD also predicts worse cardiovascular out-
comes. In the Women’s Ischemia Syndrome Evaluation 
study, larger BD (but not FMD) was an independent 
predictor of coronary artery disease in women with 
chest pain. 36 The Cardiovascular Health Study dem-
onstrated a relationship between larger BD and an 
increased risk of cardiovascular events. 11 In MESA, 
BD was associated with cardiovascular events inde-
pendent of the Framingham risk score; however, 
the relationship was not seen in the fi nal multivari-
able model. 16 
 There are several possible explanations for the 
associations between BD and RV parameters in our 
study. Peripheral endothelial dysfunction has been 
linked with increased LV mass in MESA and other 
cohorts, independent of BP. 1,2,37-39 Nitric oxide sig-
naling is also associated with cardiac remodeling and 
hypertrophy. 40,41 Therefore, an afterload-independent 
relationship between the peripheral vasculature and 
cardiac morphology (eg, mediated by neurohormonal 
activation) may provide a potential explanation for 
associations with RV morphology in this study. 
 Larger BD may also be a surrogate marker for 
pulmonary vascular remodeling, which could impact 
the RV through subclinical increases in afterload. 
Studies using a variety of methodologies have linked 
peripheral endothelial function with pulmonary vas-
cular disease. 4-6,42 Given the relationship between 
systemic and pulmonary vascular function (and the 
 Table 3— Linear Regression Models of the Association Between Brachial Artery Ultrasonography 
and RV Parameters (n  5 2,425) 
Parameter
Limited Model a Adjusted Model b Adjusted Model  1 LV c 
 b 95% CI  P Value  b 95% CI  P Value  b 95% CI  P Value
RV mass
 Baseline diameter 0.53 0.33-0.74  , .001 0.55 0.34-0.76  , .001 0.35 0.15-0.55 .001
 FMD  2 0.04  2 0.09-0.01 .08  2 0.04  2 0.09-0.01 .09  2 0.01  2 0.06-0.04 .67
RVEDV
 Baseline diameter 3.83 2.34-5.33  , .001 3.99 2.50-5.48  , .001 1.86 0.77-2.95 .001
 FMD  2 0.36  2 0.68- 2 0.04 .03  2 0.37  2 0.69- 2 0.05 .02  2 0.07  2 0.31-0.17 .56
RVEF
 Baseline diameter  2 0.39  2 0.81-0.03 .07  2 0.46  2 0.89- 2 0.04 .03  2 0.35  2 0.74-0.03 .07
 FMD 0.05  2 0.05-0.30 .31 0.05  2 0.04-0.15 .28 0.04  2 0.05-0.13 .34
 b represents the change in the respective RV parameter (g for RV mass, mL for RVEDV, and % for RVEF) associated with a 1-unit increment of 
the vascular parameter (1 mm for baseline diameter, 1% for FMD). LV  5 left ventricular. See Table 2 legend for expansion of other abbreviations.
 a Limited model includes age, sex, race/ethnicity, height and weight, waist circumference, systolic BP, and diastolic BP.
 b Adjusted model includes all covariates from limited model with the addition of statin use, hypertension medication use, diabetes, smoking status, 
pack-years, education level, and exercise.
 c Indicates the addition of the relevant LV parameter (eg, LV mass for model with RV mass).
1404 Original Research
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article. 
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exclusion of participants who may have had SDB. 32,46 
We did not have brachial artery or RV measures 
available in all participants; however, we incorporated 
weighting into our analysis and those included in the 
study sample were similar to those excluded. 
 In summary, we have described a strong associa-
tion between brachial artery BD and RV morphology. 
The relationship between RV mass and function and 
peripheral vascular structure warrants further studies 
to determine how these fi ndings impact subclinical 
and clinical heart and lung disease. Future investiga-
tion of the relationships between brachial artery BD 
and RV afterload and perfusion may elucidate the 
mechanisms that explain these fi ndings. 
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